Figure 3.
Association of miRNA expression and clinicopathological parameters in pRCC sera. (A) Normalized miR-21-5p and (B) miR-210-3p expression in healthy control sera, localized and advanced pRCC disease, divided into the respective participating centers (left plots) and subsequent cross-cohort comparison (right plots). (C) AUC curves regarding the diagnostic accuracy of normalized miR-210-3p (left plot), miR-21-5p (middle plot) expression and a combination of both (right plot) regarding localized and advanced pRCC. *, P<0.05; **, P<0.01; ***, P<0.001.